NCT03907176: A trial that was reported late by Heron Therapeutics
This trial has reported, although it was 226 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT03907176 |
|---|---|
| Title | A Phase 3b, Randomized, Open-Label Study of HTX-011 as the Foundation of a Non-opioid, Multimodal Analgesic Regimen to Decrease Opioid Use Following Unilateral Open Inguinal Herniorrhaphy |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | April 5, 2019 |
| Completion date | Oct. 25, 2021 |
| Required reporting date | Oct. 25, 2022, midnight |
| Actual reporting date | June 8, 2023 |
| Date last checked at ClinicalTrials.gov | Dec. 12, 2025 |
| Days late | 226 |